trending Market Intelligence /marketintelligence/en/news-insights/trending/ogxIdTKdaAU-T8QMKjQOUQ2 content esgSubNav
In This List

Sundrug fiscal Q1 profit falls YOY

Blog

Corporate Credit Risk Trends in Developing Markets An Expected Credit Loss ECL Perspective

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Q&A: Data That Delivers - Automating the Credit Risk Workflow


Sundrug fiscal Q1 profit falls YOY

Sundrug Co. Ltd. said its normalized net income for the fiscal first quarter ended June 30 was ¥26.69 per share, a decline of 18.3% from ¥32.66 per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥3.36 billion, a decrease of 18.3% from ¥4.12 billion in the prior-year period.

The normalized profit margin declined to 3.3% from 3.8% in the year-earlier period.

Total revenue declined 6.7% on an annual basis to ¥100.77 billion from ¥108.01 billion, and total operating expenses declined 6.0% from the prior-year period to ¥95.48 billion from ¥101.59 billion.

Reported net income fell 15.1% on an annual basis to ¥3.31 billion, or ¥26.27 per share, from ¥3.90 billion, or ¥30.93 per share.

As of Aug. 13, US$1 was equivalent to ¥102.37.